| Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis E Tacconelli, E Carrara, A Savoldi, S Harbarth, M Mendelson, DL Monnet, ... The Lancet infectious diseases 18 (3), 318-327, 2018 | 4909 | 2018 |
| Repurposed antiviral drugs for Covid-19—interim WHO solidarity trial results WHO Solidarity Trial Consortium New England journal of medicine 384 (6), 497-511, 2021 | 2629 | 2021 |
| The global threat of antimicrobial resistance: science for intervention I Roca, M Akova, F Baquero, J Carlet, M Cavaleri, S Coenen, J Cohen, ... New microbes and new infections 6, 22-29, 2015 | 1275 | 2015 |
| Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis in World Health Organization regions A Savoldi, E Carrara, DY Graham, M Conti, E Tacconelli Gastroenterology 155 (5), 1372-1382. e17, 2018 | 998 | 2018 |
| Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development E Tacconelli ICAN: Infection Control Africa Network, 2017 | 879 | 2017 |
| Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe R Köck, K Becker, B Cookson, JE van Gemert-Pijnen, S Harbarth, ... Eurosurveillance 15 (41), 2010 | 853 | 2010 |
| ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug‐resistant Gram‐negative bacteria in hospitalized patients E Tacconelli, MA Cataldo, SJ Dancer, G De Angelis, M Falcone, U Frank, ... Clinical Microbiology and Infection 20, 1-55, 2014 | 808 | 2014 |
| Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and … D Baur, BP Gladstone, F Burkert, E Carrara, F Foschi, S Döbele, ... The Lancet Infectious Diseases 17 (9), 990-1001, 2017 | 708 | 2017 |
| Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis E Tacconelli, G De Angelis, MA Cataldo, E Pozzi, R Cauda Journal of antimicrobial chemotherapy 61 (1), 26-38, 2008 | 585 | 2008 |
| Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective … B Gutiérrez-Gutiérrez, E Salamanca, M de Cueto, PR Hsueh, P Viale, ... The Lancet Infectious Diseases 17 (7), 726-734, 2017 | 479 | 2017 |
| Systematic reviews: CRD's guidance for undertaking reviews in health care E Tacconelli The Lancet Infectious Diseases 10 (4), 226, 2010 | 426 | 2010 |
| European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli … M Paul, E Carrara, P Retamar, T Tängdén, R Bitterman, RA Bonomo, ... Clinical Microbiology and Infection 28 (4), 521-547, 2022 | 403 | 2022 |
| Monitoring approaches for health-care workers during the COVID-19 pandemic JA Bielicki, X Duval, N Gobat, H Goossens, M Koopmans, E Tacconelli, ... The Lancet infectious diseases 20 (10), e261-e267, 2020 | 340 | 2020 |
| Surveillance for control of antimicrobial resistance E Tacconelli, F Sifakis, S Harbarth, R Schrijver, M van Mourik, A Voss, ... The Lancet Infectious Diseases 18 (3), e99-e106, 2018 | 304 | 2018 |
| Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: guidance from … AP Magiorakos, K Burns, J Rodríguez Baño, M Borg, G Daikos, U Dumpis, ... Antimicrobial Resistance & Infection Control 6, 1-17, 2017 | 266 | 2017 |
| Combination therapy for carbapenem-resistant Gram-negative bacteria M Paul, Y Carmeli, E Durante-Mangoni, JW Mouton, E Tacconelli, ... Journal of Antimicrobial Chemotherapy 69 (9), 2305-2309, 2014 | 258 | 2014 |
| Critical analysis of antibacterial agents in clinical development U Theuretzbacher, K Bush, S Harbarth, M Paul, JH Rex, E Tacconelli, ... Nature Reviews Microbiology 18 (5), 286-298, 2020 | 254 | 2020 |
| In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors A Cassone, F De Bernardis, A Torosantucci, E Tacconelli, M Tumbarello, ... The Journal of infectious diseases 180 (2), 448-453, 1999 | 247 | 1999 |
| Mupirocin Prophylaxis to Prevent Staphylococcus aureus Infection in Patients Undergoing Dialysis: A Meta-analysis E Tacconelli, Y Carmeli, A Aizer, G Ferreira, MG Foreman, EMC D'Agata Clinical infectious diseases 37 (12), 1629-1638, 2003 | 246 | 2003 |
| Metallo-β-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues G Cornaglia, M Akova, G Amicosante, R Cantón, R Cauda, JD Docquier, ... International journal of antimicrobial agents 29 (4), 380-388, 2007 | 236 | 2007 |
